Showing results (301-310 of 321) with videos related to

Sort By:
Pageof 33
American Journal of Human Genetics|May 16, 2001
Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneityJ D Buxbaum, J M Silverman, C J Smith, et al.
Archives of Neurology|December 26, 2001
Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive declineS Parvathy, P Davies, V Haroutunian, et al.
Comprehensive Psychiatry|July 18, 2001
The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophreniaP D Harvey, M R Serper, L White, et al.
The American Journal of Psychiatry|March 1, 1993
Schizophrenia-related and affective personality disorder traits in relatives of probands with schizophrenia and personality disordersJ M Silverman, L J Siever, T B Horvath, et al.
The American Journal of Psychiatry|February 1, 1994
Lack of association between cortisol hypersecretion and nonsuppression on the DST in patients with Alzheimer's diseaseA H Miller, G Sastry, A J Speranza, et al.
The American Journal of Psychiatry|December 1, 1981
Neuroendocrine and neurochemical measurements in depressionK L Davis, L E Hollister, A A Mathé, et al.
Neurology|February 19, 2000
A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative StudyP S Aisen, K L Davis, J D Berg, et al.
Psychiatry Research|December 1, 1993
Post-mortem examination of dopaminergic parameters in Alzheimer's disease: relationship to noncognitive symptomsL M Bierer, P J Knott, J M Schmeidler, et al.
Molecular Psychiatry|July 1, 1996
Ventricular enlargement associated with linkage marker for schizophrenia-related disorders in one pedigreeL Shihabuddin, J M Silverman, M S Buchsbaum, et al.
The New England Journal of Medicine|October 29, 1992
A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study GroupK L Davis, L J Thal, E R Gamzu, et al.
Pageof 33